Boosting L-type Ca2+ channel activity in tuberous sclerosis mitigates excess glutamate receptors
Farr Niere, Luisa P. Cacheaux, Hailey X. Egido‐Betancourt, William C. Taylor, Kimberly F. Raab‐Graham
The paper identifies Bay-K8644 as a potential therapy for TS-related seizures by boosting L-type Ca2+ channel activity and reducing excess GluA receptors in a mouse model.
bioRxiv · Aug 26, 2020 · PreprintNeuroscience